Stock

Nasdaq:

DEPO

Price:

3.49 +0.00

Volume:

66,633

20 minute delay

In The News

May 1, 2008 Depomed Reports First Quarter 2008 Financial Results

April 24, 2008 Depomed to Announce First Quarter 2008 Financial Results on May 1, 2008

April 8, 2008 Depomed Elects Karen A. Dawes to Board of Directors

April 7, 2008 Depomed Settles Patent Litigation Against IVAX

March 24, 2008 Depomed Doses First Patient in New Phase 3 Clinical Trial of Gabapentin GR in Postherpetic Neuralgia